✦ LIBER ✦

Sublingual L-hyoscyamine for duodenal antimotility during ERCP: a prospective randomized double-blinded study

✍ Scribed by Christopher R. Lynch; Suresh Khandekar; Scott M. Lynch; James A. DiSario

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of duodenal motility during

✍ Moses, P.L.; Alkhatib, O.; Mitty, R.; Ferrentino, N.; Rothstein, R.; Callas, P.W 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Sublingual hyoscyamine for patient comfo

✍ John A. Dumot; Edwardo Verzola; Sylvester Nicol; Kirk A. Easley; John J. Vargo; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 22 KB

A prospective, double-blind trial of L-h

✍ Sandeep Lahoti; Marc F. Catalano; Joseph E. Geenen; Walter J. Hogan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Nifedipine for prevention of post-ERCP p

✍ Frédéric Prat; Juan Amaris; Béatrice Ducot; Muriel Bocquentin; Jacques Fritsch; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Nifedipine for post-ERCP pancreatitis pr

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

A prospective, double-blind trial of L-h

✍ MF Catalano; J Geenen; A Bohorfoush; M Schmalz; GK Johnson; W Hogan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 148 KB